CP
AGIO icon

CenterBook Partners’s Agios Pharmaceuticals AGIO Stock Holding History

CenterBook Partners’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$590K Buy
+17,445
New +$495K 0.03% 453
2025
Q3 		– Sell
-243,063
Closed -$8.08M – 550
2025
Q2 		$8.08M Buy
243,063
+134,554
+124% +$4.08M 0.45% 48
2025
Q1 		$3.18M Sell
108,509
-197,090
-64% -$6.54M 0.2% 134
2024
Q4 		$10M Buy
305,599
+151,511
+98% +$7.12M 0.6% 35
2024
Q3 		$6.85M Sell
154,088
-95,223
-38% -$4.32M 0.42% 72
2024
Q2 		$10.8M Buy
+249,311
New +$9M 0.67% 24

Other funds holding AGIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

CenterBook Partners's AGIO Position: Q1 2026 in Review

CenterBook Partners opened a new position in Agios Pharmaceuticals (AGIO) in Q1 2026: 17,445 shares worth $590K. The stake represents 0.03% of the portfolio and ranks #453 among its holdings. This is a return to the name: CenterBook Partners previously reported a position in AGIO as recently as Q2 2025.

CenterBook Partners first reported a position in AGIO in Q2 2024 and has held it in 6 quarters since. The position peaked at $10.8M in Q2 2024. 233 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • CenterBook Partners held 17,445 shares of Agios Pharmaceuticals worth $590K as of Q1 2026.
  • Agios Pharmaceuticals was a new CenterBook Partners position in Q1 2026.
  • Agios Pharmaceuticals made up 0.03% of CenterBook Partners's portfolio in Q1 2026, its #453 holding.
  • CenterBook Partners first reported a position in Agios Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
  • CenterBook Partners's Agios Pharmaceuticals position peaked at $10.8M in Q2 2024.
  • 233 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on CenterBook Partners's 13F filing for Q1 2026, filed 5 May 2026.